Clinical Trial

Reference Values for Gastric Emptying Scintigraphy After Bariatric Surgery

Study acronym: SCATTER
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Oesophageal and gastric scintigraphy evaluates the function of the gastrointestinal system including variables such as oesophageal transit and gastric emptying (GE). Some variables are known to change after bariatric surgery. In patients that have symptoms of pain or nausea after bariatric surgery, oesophageal and gastric scintigraphy plays an important role in determining the nature of symptoms and is necessary for adequate treatment. However, literature on reference values in the bariatric population are scarce. At this moment, quantitative evaluation of the scintigraphy cannot be performed and conclusions are based on visual interpretation. There is a need for a standardised scintigraphy protocol for the population that underwent bariatric surgery taking into account the changed anatomy and physiology. Then, reference values that describe the oesophageal transit and GE assessed using scintigraphy have to be determined.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-25; most recent amendment 2025-03-05.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-03-05
Trial Details
NCT Number NCT06391255
Lead Sponsor Rijnstate Hospital
Conditions Gastric Emptying, Bariatric Surgery
Enrollment 50 participants
Start Date 2024-05-29
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-10